User login
NEW ORLEANS – Available medications to treat CML are giving rise to new questions. For instance, why do some patients respond to some medications better than others? How can side effects best be managed? And how can treatment be stopped safely?
In an exclusive interview at the American Society of Hematology's annual meeting, Dr. Richard E. Clark of Royal Liverpool University Hospital, Liverpool, United Kingdom, provides an overview of the field and its future.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
NEW ORLEANS – Available medications to treat CML are giving rise to new questions. For instance, why do some patients respond to some medications better than others? How can side effects best be managed? And how can treatment be stopped safely?
In an exclusive interview at the American Society of Hematology's annual meeting, Dr. Richard E. Clark of Royal Liverpool University Hospital, Liverpool, United Kingdom, provides an overview of the field and its future.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
NEW ORLEANS – Available medications to treat CML are giving rise to new questions. For instance, why do some patients respond to some medications better than others? How can side effects best be managed? And how can treatment be stopped safely?
In an exclusive interview at the American Society of Hematology's annual meeting, Dr. Richard E. Clark of Royal Liverpool University Hospital, Liverpool, United Kingdom, provides an overview of the field and its future.
